We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 16, 2009

MERCK SHARP & DOHME CORP. et al v. MYLAN PHARMACEUTICALS INC. et al

Track this case

Case Number:

2:09-cv-06383

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Jose L. Linares

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. April 27, 2012

    Merck Defeats Mylan's Challenge To Zetia, Vytorin Patent

    A Merck & Co. Inc. unit prevailed Friday in a patent suit against Mylan Pharmaceuticals Inc. over its generic versions of cholesterol drugs Zetia and Vytorin, with a New Jersey federal judge ruling valid Merck's patent on an active ingredient of the drugs.

1 other articles on this case. View all »

Parties

To view the parties, register now.